2004
DOI: 10.1078/0944711041495227
|View full text |Cite
|
Sign up to set email alerts
|

Analgesic and anti-inflammatory activities of a fraction rich in oncocalyxone A isolated from Auxemma oncocalyx

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
27
0
4

Year Published

2008
2008
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 43 publications
(32 citation statements)
references
References 43 publications
1
27
0
4
Order By: Relevance
“…Moreover, only DXR and A. oncocalyx exhibited an increase in oocytes with abnormal chromatin configuration, showing less harmful effect of onco A. This result may be due to the impurity of the fraction of A. oncocalyx that contains 80% of onco A (FERREIRA et al, 2004), and 20% of other substances that may be more toxic than onco A alone. In addition, Pessoa et al (PESSOA et al, 2003)increasing the risk for the development of a second cancer, particularly acute leukemia.…”
Section: Resultsmentioning
confidence: 76%
See 2 more Smart Citations
“…Moreover, only DXR and A. oncocalyx exhibited an increase in oocytes with abnormal chromatin configuration, showing less harmful effect of onco A. This result may be due to the impurity of the fraction of A. oncocalyx that contains 80% of onco A (FERREIRA et al, 2004), and 20% of other substances that may be more toxic than onco A alone. In addition, Pessoa et al (PESSOA et al, 2003)increasing the risk for the development of a second cancer, particularly acute leukemia.…”
Section: Resultsmentioning
confidence: 76%
“…Notably, the fraction of A. oncocalyx contained 80% of onco A (FERREIRA et al, 2004), therefore the concentration of A. oncocalyx was in equal proportion of onco A. A. oncocalyx and onco A were diluted with dimethyl sulfoxide (DMSO) as a vehicle.…”
Section: Source Of Ovariesmentioning
confidence: 99%
See 1 more Smart Citation
“…7,[10][11][12] Oncocalyxone A (1) also showed differential antitumor activity against the murine tumors Ehrlich carcinoma, sarcoma 180 and L1210 leukemia. Other pharmacological activities were also ascribed to the quinone fraction obtained from A. oncocalyx extract.…”
Section: Introductionmentioning
confidence: 99%
“…6, 2012 of platelet activation. 3,4,[5][6][7][8] Oncocalyxone A also shows differential antitumor activity against the murine tumors Ehrlich carcinoma, sarcoma 180 and L1210 leukemia. 8 In general, two major mechanisms of quinone cytotoxicity have been proposed: stimulation of oxidative stress and alkylation of cellular nucleophiles, which encompass large range of biomolecules, 9 such as DNA and some enzymes, e.g., topoisomerase and protein tyrosine phosphatases, mainly those with thiol groups.…”
Section: Introductionmentioning
confidence: 99%